Scientists engineered a stabilized, native-like E1E2 glycoprotein complex from hepatitis C virus and incorporated it into a nanoparticle vaccine platform. The approach overcomes a decades-long ...

In a study published in Scientific Reports, researchers from Spain developed a method to design vaccines for highly variable viruses like the hepatitis C virus (HCV) using combinatorial optimization.

Around 300,000 people die from hepatitis C every year. A new study has mapped the protein complex that enables the virus to infect our cells, potentially paving the way for an effective vaccine.